BusinessCBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish SolutionBy Nasdaq OMXJan 18, 2018, 9:16 PM UTC
BusinessCellular Biomedicine Group Announces Closing of $14.5 Million Private Placement OfferingBy Nasdaq OMXDec 28, 2017, 12:30 PM UTC
BusinessCellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational HighlightsBy Nasdaq OMXNov 9, 2017, 1:30 PM UTC
BusinessThermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic Partnership to Develop Manufacturing ProcessesBy Nasdaq OMXNov 6, 2017, 12:20 PM UTC
BusinessCellular Biomedicine Group Executives to Present at Biotech and Money World HealthEx Forum in LondonBy Nasdaq OMXOct 31, 2017, 12:01 PM UTC
BusinessCellular Biomedicine Group Reports Second Quarter and First Half 2017 Financial Results and Business HighlightsBy Nasdaq OMXAug 8, 2017, 8:31 PM UTC
BusinessCellular Biomedicine Group (CBMG) Appoints Dr. Xia Meng as Chief Operating Officer to Lead Commercialization of the Company’s CAR-T and Stem Cell ProductsBy Nasdaq OMXJun 26, 2017, 11:28 AM UTC
BusinessCellular Biomedicine Group Appoints Michael A. Caligiuri, MD as Chair of External Advisory BoardBy Nasdaq OMXJun 20, 2017, 10:00 AM UTC
